Mind the Gap:

Supporting Cross-Functional Teams with Corporate-Level Competitive Intelligence

Competitive intelligence in biopharma is typically strong at the asset and indication level but often fragmented at the corporate level. Leadership teams are left without a clear, consistent view of how peer companies signal priorities, allocate capital, and position for what comes next.

This report defines corporate level peer analysis as a distinct CI discipline and outlines how teams can operationalize it to support strategy, portfolio planning, and investment decisions.

Share:

Competitive intelligence teams generate strong insight at the brand and indication level.

At the corporate level, peer analysis is harder to sustain and often fragmented. Leadership lacks a consistent view of how peer companies signal priorities, allocate capital, and position for what comes next.

In this report, we explore corporate-level peer analysis as a distinct CI activity and outline a structured approach for making it more consistent, more interpretable, and more useful for enterprise decision making.

We provide practical guidance to bridge the gap that many organizations face between detailed bottom-up intelligence and the top-down insight needed to support strategy, investment, and planning decisions.

The report highlights

  • What corporate-level peer analysis looks like in practice and how it complements indication-level CI
  • Why ownership, resourcing, and consistency often break down at the enterprise level
  • A four-pillar framework for sustaining peer analysis over time
  • How to monitor competitive signals and identify macro themes across a defined peer set
  • Ways to translate activity into executive-level comparison that supports decision making

Upcoming Webinar

World Preview 2026

Tuesday 16th June 2026 | 3pm BST

By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.

Frequently Asked Questions

Corporate-level peer analysis evaluates companies rather than individual assets or indications. It focuses on strategic priorities, capital allocation, portfolio direction, and longer-term positioning across a defined set of peer organizations.

It provides a structured way to connect bottom-up intelligence to enterprise-level implications, improving consistency, interpretation, and relevance for senior decision makers.

Ownership is frequently unclear, resources are limited, and processes vary across teams. Without a dedicated workstream, analysis becomes reactive and inconsistent.

Traditional CI typically operates at the therapy area or asset level. Corporate-level peer analysis takes a top-down view across portfolios and companies to surface broader strategic patterns.

Yes. The report outlines a four-pillar approach covering peer set determination, monitoring, macro themes and trends, and executive-level comparison.

Related Posts